India’s bioeconomy has witnessed an extraordinary leap over the last decade, growing from just $10 billion in 2014 to $165.7 billion in 2024, according to official data. With an ambitious target of $300 billion by 2030, the sector is emerging as a key driver of the country’s sustainable development, integrating biotechnology, agriculture, energy, and healthcare.
The expansion is largely attributed to progress in four subsectors: BioIndustrial (47 per cent), BioPharma (35 per cent), BioResearch (9 per cent), and BioAgri (8 per cent). Together, these areas form the foundation of India’s bioeconomy, which is increasingly being recognised as a global force in both innovation and sustainability.
One of the standout achievements has been India’s strengthened position as a global vaccine manufacturer. The World Health Organization’s Global Vaccine Market Report highlights that the Serum Institute of India increased its global vaccine share (excluding Covid-19 vaccines) from 19 per cent in 2021 to 24 per cent in 2024. This growth came on the back of higher production of pneumococcal conjugate, measles-rubella, and tetanus-diphtheria vaccines. Alongside Serum Institute, Bharat Biotech, and Biological E, India has placed India among the top three contributors to the global vaccine market. Collectively, Indian firms supplied 40 per cent of the WHO’s vaccine purchases, with a notable 20 per cent exported to the African region.
India’s bioeconomy success also extends to clean energy integration through ethanol blending. In 2025, the country achieved 20 per cent ethanol blending (E20) in petrol, five years ahead of schedule. The rise has been dramatic, from just 1.5 per cent in 2014 to 20 per cent today, providing economic and environmental gains. Farmers benefited directly, receiving Rs 1,21,000 crore for ethanol feedstock between 2014-15 and June 2025. This eliminated sugarcane arrears while boosting maize cultivation. For the current year alone, payments to farmers are expected to reach Rs 40,000 crore, while foreign exchange savings are estimated at Rs 43,000 crore.
Cumulatively, till July 2025, ethanol blending has substituted 245 lakh metric tonnes of crude oil and conserved Rs 1,44,087 crore in foreign exchange, strengthening India’s energy security while contributing to emission reduction.
Policy reforms have further accelerated growth. In August 2024, the Union Cabinet approved the country’s first biotechnology policy, the BioE3 Policy (Biotechnology for Economy, Environment and Employment). The policy, designed by the Department of Biotechnology, aims to foster high-performance biomanufacturing and introduces the Biomanufacturing and Biofoundry Initiative. By shifting from consumptive to regenerative practices, the initiative seeks to promote green growth and sustainability.
Beyond economic gains, the bioeconomy has been positioned as a tool to address climate change. By integrating bioenergy, cleaner farming, recycling, carbon storage, and greener industrial processes, it has the potential to lower emissions while enhancing resource efficiency.
India’s rapid rise in the bioeconomy underlines its dual commitment to economic expansion and sustainability. With a clear roadmap, global vaccine leadership, and ambitious ethanol blending milestones, the sector is poised to play a defining role in shaping the country’s green future.
